Imunon, Inc. Deferred Revenue
Imunon, Inc. (IMNN) had Deferred Revenue of $500.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-11-14
- 2018-09-30: Deferred Revenue, Current $500.00K.
- 2018-06-30: Deferred Revenue, Current $500.00K.
- 2018-03-31: Deferred Revenue, Current $500.00K.
- 2017-12-31: Deferred Revenue, Current $500.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-09-30 | $500.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $500.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $500.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $500.00K 10-Q · filed 2018-11-14 |
| 2017-09-30 | $500.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $500.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $500.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $500.00K 10-K · filed 2018-03-27 |
| 2016-09-30 | $500.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $500.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $500.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $500.00K 10-K · filed 2017-03-24 |
| 2015-09-30 | $500.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $500.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $500.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $500.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $500.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $500.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $500.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $500.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $500.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $500.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $500.00K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |